Literature DB >> 7636721

Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.

P Clausing1, B Gough, R R Holson, W Slikker, J F Bowyer.   

Abstract

Extracellular levels of d-amphetamine (AMPH) in caudate/putamen were determined using microdialysis and HPLC quantitation after s.c. doses that produced increased motor activity (1 mg/kg), stereotypic behavior (2.5 mg/kg) or dopamine depletion in the caudate/putamen (4 x 5 mg/kg). In 6-mo-old rats exposed to neurotoxic doses of AMPH sulfate (4 x 5 mg/kg in a 23 degrees C environment), extracellular caudate/putamen AMPH rose to levels of 7.9 +/- 0.9 microM after the first dose and peaked at 15.1 +/- 2.5 microM after the third dose with no further increases after the fourth dose. After one or three doses of 5 mg/kg, peak plasma and tissue levels of AMPH were 1.7 +/- 0.2 and 2.9 +/- 0.3 microM in plasma, 36 +/- 6 and 73 +/- 10 in substantia nigra and 25 +/- 4 and 50 +/- 8 in caudate/putamen, respectively. Caudate/putamen extracellular AMPH levels were about three times higher (in either 6- or 12-mo-old rats) after 4 x 15 mg/kg in a 10 degrees C environment and tissue levels in caudate/putamen and substantia nigra were three to five times higher after three doses of AMPH. However, these higher levels did not produce dopamine depletion in the caudate/putamen, while the lower doses (4 x 5 mg/kg) given at 23 degrees C did. Estimated caudate/putamen extracellular AMPH levels of 2.5 to 5 microM after single doses (1 and 2.5 mg/kg) that caused hyperactivity and stereotypic behavior are compatible with the 2 to 10 microM AMPH concentrations reported to be necessary to produce pronounced dopamine release in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7636721

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  19 in total

1.  4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Authors:  Gregory C Hadlock; Katy M Webb; Lisa M McFadden; Pei Wen Chu; Jonathan D Ellis; Scott C Allen; David M Andrenyak; Paula L Vieira-Brock; Christopher L German; Kevin M Conrad; Amanda J Hoonakker; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2011-08-02       Impact factor: 4.030

2.  Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization.

Authors:  Christopher L German; Glen R Hanson; Annette E Fleckenstein
Journal:  J Neurochem       Date:  2012-08-23       Impact factor: 5.372

3.  Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo.

Authors:  Eric S Ramsson; Daniel P Covey; David P Daberkow; Melissa T Litherland; Steven A Juliano; Paul A Garris
Journal:  J Neurochem       Date:  2011-05-03       Impact factor: 5.372

4.  Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.

Authors:  V Sandoval; E L Riddle; Y V Ugarte; G R Hanson; A E Fleckenstein
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

5.  Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.

Authors:  Mattias Rickhag; William A Owens; Marie-Therese Winkler; Kristine Nørgaard Strandfelt; Mette Rathje; Gunnar Sørensen; Bjørn Andresen; Kenneth L Madsen; Trine Nygaard Jørgensen; Gitta Wörtwein; David P D Woldbye; Harald Sitte; Lynette C Daws; Ulrik Gether
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

6.  Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.

Authors:  Kristin E Larsen; Edward A Fon; Teresa G Hastings; Robert H Edwards; David Sulzer
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

7.  An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens.

Authors:  R Kuczenski; D S Segal
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

8.  Amphetamine distorts stimulation-dependent dopamine overflow: effects on D2 autoreceptors, transporters, and synaptic vesicle stores.

Authors:  Y Schmitz; C J Lee; C Schmauss; F Gonon; D Sulzer
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

9.  Brain concentrations of d-MDMA are increased after stress.

Authors:  Elizabeth Anne Johnson; James P O'Callaghan; Diane B Miller
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

10.  Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux.

Authors:  Francesca Binda; Concetta Dipace; Erica Bowton; Sabrina D Robertson; Brandon J Lute; Jacob U Fog; Minjia Zhang; Namita Sen; Roger J Colbran; Margaret E Gnegy; Ulrik Gether; Jonathan A Javitch; Kevin Erreger; Aurelio Galli
Journal:  Mol Pharmacol       Date:  2008-07-10       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.